Functional analysis of choline transporters in rheumatoid arthritis synovial fibroblasts

References

• Smolen JS, Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov. 2003;2:473–88.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet 2007;370:1861–74.
   PubMed Web of Science ®Google Scholar
• Yamamura Y, Shelden E, Fox DA. Interactions between T cells and synovial fibroblasts. Mod Rheumatol. 2000;10:16–18.
   PubMedGoogle Scholar
• Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233:233–55.
   PubMed Web of Science ®Google Scholar
• Sen M, Carson DA. Wnt signaling in rheumatoid synoviocyte activation. Mod Rheumatol. 2002;12:5–9.
   PubMedGoogle Scholar
• Michel V, Yuan Z, Ramsubir S, Bakovic M. Choline transport for phospholipid synthesis. Exp Biol Med (Maywood). 2006; 231:490–504.
   PubMed Web of Science ®Google Scholar
• Inazu M. Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy. Biopharm Drug Dispos. 2014;35:431–49.
   PubMed Web of Science ®Google Scholar
• Beckmann J, Schubert J, Morhenn HG, Grau V, Schnettler R, Lips KS. Expression of choline and acetylcholine transporters in synovial tissue and cartilage of patients with rheumatoid arthritis and osteoarthritis. Cell Tissue Res. 2015;359:465–77.
   PubMed Web of Science ®Google Scholar
• Kasamatsu A, Satoh M, Yoshida T, Kosaka T. Response of human fibroblast-like synoviocytes derived from rheumatoid arthritis to inflammatory stimulation: quality control findings. Tiss Cult Res Commun. 2010;29:167–72.
   Google Scholar
• Cheng Y, Prusoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973;22:3099–108.
   PubMed Web of Science ®Google Scholar
• Inazu M, Takeda H, Matsumiya T. Molecular and functional characterization of an Na+-independent choline transporter in rat astrocytes. J Neurochem. 2005;94:1427–37.
   PubMed Web of Science ®Google Scholar
• Yabuki M, Inazu M, Yamada T, Tajima H, Matsumiya T. Molecular and functional characterization of choline transporter in rat renal tubule epithelial NRK-52E cells. Arch Biochem Biophys. 2009; 485:88–96.
   PubMed Web of Science ®Google Scholar
• Taguchi C, Inazu M, Saiki I, Yara M, Hara N, Yamanaka T, et al. Functional analysis of [methyl-(3)H]choline uptake in glioblastoma cells: influence of anti-cancer and central nervous system drugs. Biochem Pharmacol. 2014;88:303–12.
   PubMed Web of Science ®Google Scholar
• Kouji H, Inazu M, Yamada T, Tajima H, Aoki T, and Matsumiya T. Molecular and functional characterization of choline transporter in human colon carcinoma HT-29 cells. Arch Biochem Biophys. 2009;483:90–8.
   PubMed Web of Science ®Google Scholar
• Yamada T, Inazu M, Tajima H, Matsumiya T. Functional expression of choline transporter-like protein 1 (CTL1) in human neuroblastoma cells and its link to acetylcholine synthesis. Neurochem Int. 2011;58:354–65.
   PubMed Web of Science ®Google Scholar
• Yara M, Iwao B, Hara N, Yamanaka T, Uchino H, Inazu M. Molecular and functional characterization of choline transporter in the human trophoblastic cell line JEG-3 cells. Placenta. 2015;36:631–7.
   PubMed Web of Science ®Google Scholar
• Iwao B, Yara M, Hara N, Kawai Y, Yamanaka T, Nishihara H, et al. Functional expression of choline transporter like-protein 1 (CTL1) and CTL2 in human brain microvascular endothelial cells. Neurochem Int. 2016;93:40–50.
   PubMed Web of Science ®Google Scholar
• Inazu M, Yamada T, Kubota N, Yamanaka T. Functional expression of choline transporter-like protein 1 (CTL1) in small cell lung carcinoma cells: a target molecule for lung cancer therapy. Pharmacol Res. 2013;76:119–31.
   PubMed Web of Science ®Google Scholar
• Nishiyama R, Nagashima F, Iwao B, Kawai Y, Inoue K, Midori A, et al. Identification and functional analysis of choline transporter in tongue cancer: a novel molecular target for tongue cancer therapy. J Pharmacol Sci. 2016;131:101–9.
   PubMed Web of Science ®Google Scholar
• Niculescu MD, Yamamuro Y, Zeisel SH. Choline availability modulates human neuroblastoma cell proliferation and alters the methylation of the promoter region of the cyclin-dependent kinase inhibitor 3 gene. J Neurochem. 2004;89:1252–9.
   PubMed Web of Science ®Google Scholar
• Albright CD, Friedrich CB, Brown EC, Mar MH, Zeisel SH. Maternal dietary choline availability alters mitosis, apoptosis and the localization of TOAD-64 protein in the developing fetal rat septum. Brain Res Dev Brain Res. 1999;115:123–9.
   PubMedGoogle Scholar
• Craciunescu CN, Albright CD, Mar MH, Song J, Zeisel SH. Choline availability during embryonic development alters progenitor cell mitosis in developing mouse hippocampus. J Nutr. 2003;133:3614–18.
   PubMed Web of Science ®Google Scholar
• Yen CL, Mar MH, Meeker RB, Fernandes A, Zeisel SH. Choline deficiency induces apoptosis in primary cultures of fetal neurons. FASEB J. 2001;15:1704–10.
   PubMed Web of Science ®Google Scholar
• Albright CD, Tsai AY, Friedrich CB, Mar MH, Zeisel SH. Choline availability alters embryonic development of the hippocampus and septum in the rat. Brain Res Dev Brain Res. 1999;113:13–20.
   PubMedGoogle Scholar
• Niculescu MD, Craciunescu CN, Zeisel SH. Gene expression profiling of choline-deprived neural precursor cells isolated from mouse brain. Brain Res Mol Brain Res. 2005;134:309–22.
   PubMedGoogle Scholar
• Fullerton MD, Wagner L, Yuan Z, Bakovic M. Impaired trafficking of choline transporter-like protein-1 at plasma membrane and inhibition of choline transport in THP-1 monocyte-derived macrophages. Am J Physiol Cell Physiol. 2006;290:C1230–8.
   PubMed Web of Science ®Google Scholar
• Maruyama N, Hirano F, Yoshikawa N, Migita K, Eguchi K, Tanaka H. Thrombin stimulates cell proliferation in human fibroblast-like synoviocytes in nuclear factor-kappaB activation and protein kinase C mediated pathway. J Rheumatol. 2000;27:2777–85.
   PubMed Web of Science ®Google Scholar